Investors shift into U.S. healthcare stocks as tech trade cools
Money moved into U.S. healthcare as Nasdaq weakness and rich AI valuations sent investors toward drugmakers, devices and managed care.
Investors on Wall Street poured into U.S. healthcare stocks as the tech trade lost momentum on Aug. 5, with buyers favoring drugmakers, medical-device companies and managed-care firms over richly priced AI and software names. The shift reflected a hunt for steadier cash generation and a defensive haven that still offers earnings upside.
The rotation was built on improving fundamentals and cheaper valuations. Large drugmakers and device makers have lagged the broader market for years, leaving many shares looking less stretched than the biggest technology stocks. The S&P 500 Health Care index stood at 1,913.00 on Aug. 5 and had delivered a 23.99% one-year price return, according to S&P Dow Jones Indices, showing how sharply sentiment had already improved before the latest buying.
Positioning had also turned more constructive. Hedge fund bets on rising U.S. healthcare stocks were near a five-year high in data Goldman Sachs highlighted on July 27, signaling that some of the market’s fastest money had already been leaning into the sector. CVS Health added to the backdrop on Aug. 5 when it raised its annual profit forecast on improved drug revenues, even though its shares fell as other quarterly issues overshadowed the stronger outlook.
The push into health care came as investors reassessed the tech complex after months of enthusiasm for artificial intelligence and high-growth software. U.S. stocks were mixed on Aug. 5, with the Nasdaq down as tech weakness persisted, and global tech shares had also faced pressure from worries about demand and profit outlook. That has made room for sectors that may not offer the same explosive narrative but do offer more stable earnings and, in some cases, clearer pricing power.
For portfolio managers, the question is whether this is a short-term trade or the start of a broader re-rating. If earnings keep improving and dealmaking accelerates, capital could keep moving toward health care, supporting share buybacks, acquisitions and research spending. Healthcare also featured in focus as U.S. futures edged higher on Aug. 3, reinforcing how often the group surfaced in summer trading.
This article was produced by Prism’s automated news system from verified source data, official records, and press releases, then run through automated quality and moderation checks before publishing. The system is built and supervised by the people who set the standards it runs under. Read our full AI policy.
Did this article answer your question?
